Literature DB >> 1853948

Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.

V O'Keane1, T G Dinan.   

Abstract

OBJECTIVE: Theoretically, d-fenfluramine should be a more selective serotonin (5-HT) challenge agent and has much greater clinical tolerance than the racemic compound that has previously been used. The authors' goal, therefore, was to look at 5-HT function in depression using the d isomer of fenfluramine as a probe.
METHOD: They evaluated central 5-HT function in 23 patients with DSM-III-R-diagnosed major depression and 16 healthy control subjects. The depressed group included 10 men and 13 women; four were outpatients, two attended a day hospital facility, and 17 were inpatients. Subjects were cannulated at 8:30 a.m. after an overnight fast. After baseline samples were drawn, 30 mg of d-fenfluramine was administered orally and blood samples were drawn over the following 5-hour period for prolactin and cortisol estimation.
RESULTS: The plasma prolactin responses of the depressed patients were significantly lower than those of the control subjects. This blunting was not related to the severity of the depression but was significantly related to the patients' levels of state anxiety. Cortisol responses as well as prolactin responses were impaired in depression. High baseline cortisol levels were correlated with the severity of depression and the presence of weight loss.
CONCLUSIONS: Overall, these findings indicate that there is diminished 5-HT responsivity in the depressed state.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853948     DOI: 10.1176/ajp.148.8.1009

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  The concept of depression as a dysfunction of the immune system.

Authors:  Brian E Leonard
Journal:  Curr Immunol Rev       Date:  2010-08

Review 2.  [Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy].

Authors:  O Moeller; C Norra; G Gründer
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

3.  Neurobiology of stress-induced reproductive dysfunction in female macaques.

Authors:  Cynthia L Bethea; Maria Luisa Centeno; Judy L Cameron
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

Review 4.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

5.  Paroxetine as a 5-HT neuroendocrine probe.

Authors:  H Kojima; T Terao; M Iwakawa; A Soya; N Inoue; Y Shiraishi; Y Son; S Soeda; N Ueda; R Yoshimura; J Nakamura
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

Review 6.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

Review 7.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

8.  Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.

Authors:  M Pecins-Thompson; N A Brown; S G Kohama; C L Bethea
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

Review 9.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

10.  Effects of aromatase inhibition and androgen activity on serotonin and behavior in male macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy; Nicola Robertson; Kristine Coleman
Journal:  Behav Neurosci       Date:  2013-03-18       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.